Effie Tzameli, PhD
Director of Research, NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) recently held its Annual Symposium at the beautiful Samberg Conference Center – MIT, in Cambridge, MA, overlooking the Charles River and the city of Boston. (Read more)
Well, based on this definition and the feedback from the post-conference evaluation survey, the 2017 NETRF Research Symposium was a smashing success. The level of engagement was extraordinary and the number of collaborations that this symposium has initiated was unmatched. And this is different and very special (as in my experience most scientific communities I have worked with are much more competitive), perhaps because of the deep appreciation of how difficult research is in neuroendocrine tumors (NETs), which in turn has helped create this special kinship. Researchers are open to sharing unpublished data and collaborations and exchange of research resources (be it a technology, an antibody, a PDX model) are the norm.
I want to thank all the speakers that joined us and shared their research, and all the attendees, many of which came from as far away as Europe and Australia to participate in our meeting. I also want to thank the NETRF staff that worked so hard to put this event together, as well as our Scientific Advisors and Board of Directors for their commitment and dedication to the Foundation.
I would like to finish by sharing with you some of the feedback we got from the meeting attendees.
Thank you all for helping make this a one-of-a-kind symposium, and see you next year!
With my best wishes